Bremer Trust National Association lifted its holdings in shares of Morgan Stanley (NYSE:MS) by 31.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 20,245 shares of the financial services provider’s stock after purchasing an additional 4,795 shares during the period. Bremer Trust National Association’s holdings in Morgan Stanley were worth $1,062,000 as of its most recent filing with the SEC.
Other large investors have also modified their holdings of the company. DSAM Partners London Ltd bought a new position in Morgan Stanley during the third quarter worth $5,273,000. BB&T Corp increased its stake in Morgan Stanley by 9.7% in the third quarter. BB&T Corp now owns 171,122 shares of the financial services provider’s stock valued at $8,243,000 after purchasing an additional 15,162 shares in the last quarter. Stifel Financial Corp increased its stake in Morgan Stanley by 301.3% in the third quarter. Stifel Financial Corp now owns 577,918 shares of the financial services provider’s stock valued at $27,842,000 after purchasing an additional 433,920 shares in the last quarter. CAPROCK Group Inc. bought a new stake in Morgan Stanley in the third quarter valued at $220,000. Finally, Donaldson Capital Management LLC bought a new stake in Morgan Stanley in the third quarter valued at $1,343,000. Institutional investors own 86.64% of the company’s stock.
Morgan Stanley (NYSE:MS) traded down $1.97 on Friday, reaching $55.48. 9,780,000 shares of the company’s stock were exchanged, compared to its average volume of 8,560,000. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 2.68. The stock has a market capitalization of $100,300.00, a PE ratio of 17.95, a price-to-earnings-growth ratio of 0.96 and a beta of 1.54. Morgan Stanley has a 52-week low of $40.06 and a 52-week high of $58.05.
Morgan Stanley (NYSE:MS) last released its earnings results on Thursday, January 18th. The financial services provider reported $0.84 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.77 by $0.07. The firm had revenue of $9.50 billion for the quarter, compared to analysts’ expectations of $9.25 billion. Morgan Stanley had a net margin of 14.10% and a return on equity of 10.03%. The company’s quarterly revenue was up 5.3% on a year-over-year basis. During the same period in the previous year, the company earned $0.81 earnings per share. sell-side analysts expect that Morgan Stanley will post 4.51 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Thursday, February 15th. Investors of record on Wednesday, January 31st will be paid a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.80%. The ex-dividend date is Tuesday, January 30th. Morgan Stanley’s payout ratio is currently 32.36%.
Several research firms have weighed in on MS. Atlantic Securities raised shares of Morgan Stanley from a “neutral” rating to an “overweight” rating and set a $61.00 price target for the company in a research note on Wednesday, January 10th. UBS Group raised shares of Morgan Stanley to an “overweight” rating in a research report on Wednesday, January 10th. Keefe, Bruyette & Woods raised shares of Morgan Stanley from a “market perform” rating to an “outperform” rating and set a $59.00 target price for the company in a research report on Tuesday, December 12th. Oppenheimer reissued a “hold” rating on shares of Morgan Stanley in a research report on Tuesday, October 17th. Finally, Citigroup reissued a “neutral” rating and set a $50.00 target price (up from $46.00) on shares of Morgan Stanley in a research report on Monday, October 9th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the company’s stock. Morgan Stanley has a consensus rating of “Buy” and a consensus target price of $54.07.
In related news, Director Alistair Darling sold 3,850 shares of the company’s stock in a transaction that occurred on Friday, November 24th. The shares were sold at an average price of $49.29, for a total transaction of $189,766.50. Following the sale, the director now directly owns 14,218 shares in the company, valued at approximately $700,805.22. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Keishi Hotsuki sold 25,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 28th. The stock was sold at an average price of $50.00, for a total transaction of $1,250,000.00. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company’s stock.
WARNING: This piece of content was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece of content on another site, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/02/04/morgan-stanley-ms-shares-bought-by-bremer-trust-national-association.html.
Morgan Stanley Company Profile
Morgan Stanley is a financial holding company. The Company’s segments include Institutional Securities, Wealth Management and Investment Management. The Company’s Institutional Securities business segment provides investment banking, sales and trading, and other services to corporations, governments, financial institutions and high-to-ultra high net worth clients.
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.